v3.26.1
Segment Information - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Disaggregation of Revenue        
Total net revenues $ 16,990 $ 15,423 $ 31,992 $ 28,766
All other        
Disaggregation of Revenue        
Net revenues 1,109 1,117 2,134 2,370
Immunology | Skyrizi        
Disaggregation of Revenue        
Net revenues 5,505 4,423 9,988 7,848
Immunology | Skyrizi | United States        
Disaggregation of Revenue        
Net revenues 4,767 3,843 8,542 6,762
Immunology | Skyrizi | International        
Disaggregation of Revenue        
Net revenues 738 580 1,446 1,086
Immunology | Rinvoq        
Disaggregation of Revenue        
Net revenues 2,525 2,028 4,644 3,746
Immunology | Rinvoq | United States        
Disaggregation of Revenue        
Net revenues 1,765 1,452 3,170 2,672
Immunology | Rinvoq | International        
Disaggregation of Revenue        
Net revenues 760 576 1,474 1,074
Immunology | Humira        
Disaggregation of Revenue        
Net revenues 756 1,180 1,444 2,301
Immunology | Humira | United States        
Disaggregation of Revenue        
Net revenues 425 802 782 1,546
Immunology | Humira | International        
Disaggregation of Revenue        
Net revenues 331 378 662 755
Neuroscience | Vraylar        
Disaggregation of Revenue        
Net revenues 1,071 900 1,976 1,665
Neuroscience | Vraylar | United States        
Disaggregation of Revenue        
Net revenues 1,068 898 1,970 1,661
Neuroscience | Vraylar | International        
Disaggregation of Revenue        
Net revenues 3 2 6 4
Neuroscience | Botox Therapeutic        
Disaggregation of Revenue        
Net revenues 1,042 928 2,051 1,794
Neuroscience | Botox Therapeutic | United States        
Disaggregation of Revenue        
Net revenues 864 775 1,706 1,498
Neuroscience | Botox Therapeutic | International        
Disaggregation of Revenue        
Net revenues 178 153 345 296
Neuroscience | Ubrelvy        
Disaggregation of Revenue        
Net revenues 392 338 731 578
Neuroscience | Ubrelvy | United States        
Disaggregation of Revenue        
Net revenues 379 330 709 563
Neuroscience | Ubrelvy | International        
Disaggregation of Revenue        
Net revenues 13 8 22 15
Neuroscience | Qulipta        
Disaggregation of Revenue        
Net revenues 350 267 646 460
Neuroscience | Qulipta | United States        
Disaggregation of Revenue        
Net revenues 289 237 539 409
Neuroscience | Qulipta | International        
Disaggregation of Revenue        
Net revenues 61 30 107 51
Neuroscience | Vyalev        
Disaggregation of Revenue        
Net revenues 256 98 457 161
Neuroscience | Vyalev | United States        
Disaggregation of Revenue        
Net revenues 128 22 217 28
Neuroscience | Vyalev | International        
Disaggregation of Revenue        
Net revenues 128 76 240 133
Neuroscience | Other Neuroscience        
Disaggregation of Revenue        
Net revenues 117 152 242 307
Neuroscience | Other Neuroscience | United States        
Disaggregation of Revenue        
Net revenues 43 71 89 146
Neuroscience | Other Neuroscience | International        
Disaggregation of Revenue        
Net revenues 74 81 153 161
Oncology | Venclexta        
Disaggregation of Revenue        
Net revenues 771 691 1,541 1,356
Oncology | Venclexta | United States        
Disaggregation of Revenue        
Net revenues 369 321 710 633
Oncology | Venclexta | International        
Disaggregation of Revenue        
Net revenues 402 370 831 723
Oncology | Imbruvica        
Disaggregation of Revenue        
Net revenues 532 754 1,088 1,492
Oncology | Imbruvica | United States        
Disaggregation of Revenue        
Net revenues 337 543 669 1,072
Oncology | Imbruvica | International        
Disaggregation of Revenue        
Collaboration revenues $ 195 $ 211 $ 419 $ 420
Collaborative Arrangement, Revenue Not from Contract with Customer, Statement of Income or Comprehensive Income [Extensible Enumeration] Total net revenues Total net revenues Total net revenues Total net revenues
Oncology | Elahere        
Disaggregation of Revenue        
Net revenues $ 211 $ 159 $ 409 $ 338
Oncology | Elahere | United States        
Disaggregation of Revenue        
Net revenues 161 138 321 303
Oncology | Elahere | International        
Disaggregation of Revenue        
Net revenues 50 21 88 35
Oncology | Epkinly        
Disaggregation of Revenue        
Net revenues 103 70 186 121
Oncology | Epkinly | United States        
Disaggregation of Revenue        
Collaboration revenues $ 64 $ 49 $ 115 $ 85
Collaborative Arrangement, Revenue Not from Contract with Customer, Statement of Income or Comprehensive Income [Extensible Enumeration] Total net revenues Total net revenues Total net revenues Total net revenues
Oncology | Epkinly | International        
Disaggregation of Revenue        
Net revenues $ 39 $ 21 $ 71 $ 36
Oncology | Other Oncology | United States        
Disaggregation of Revenue        
Net revenues 33 2 57 2
Aesthetics | Botox Cosmetic        
Disaggregation of Revenue        
Net revenues 728 692 1,396 1,248
Aesthetics | Botox Cosmetic | United States        
Disaggregation of Revenue        
Net revenues 400 410 771 705
Aesthetics | Botox Cosmetic | International        
Disaggregation of Revenue        
Net revenues 328 282 625 543
Aesthetics | Juvederm Collection        
Disaggregation of Revenue        
Net revenues 245 260 477 491
Aesthetics | Juvederm Collection | United States        
Disaggregation of Revenue        
Net revenues 103 105 188 180
Aesthetics | Juvederm Collection | International        
Disaggregation of Revenue        
Net revenues 142 155 289 311
Aesthetics | Other Aesthetics        
Disaggregation of Revenue        
Net revenues 309 327 595 642
Aesthetics | Other Aesthetics | United States        
Disaggregation of Revenue        
Net revenues 258 282 506 552
Aesthetics | Other Aesthetics | International        
Disaggregation of Revenue        
Net revenues 51 45 89 90
Other Key Products | Mavyret        
Disaggregation of Revenue        
Net revenues 295 375 646 681
Other Key Products | Mavyret | United States        
Disaggregation of Revenue        
Net revenues 133 184 316 326
Other Key Products | Mavyret | International        
Disaggregation of Revenue        
Net revenues 162 191 330 355
Other Key Products | Creon | United States        
Disaggregation of Revenue        
Net revenues 345 404 706 759
Other Key Products | Linzess        
Disaggregation of Revenue        
Net revenues 295 258 578 406
Other Key Products | Linzess | United States        
Disaggregation of Revenue        
Net revenues 283 247 555 386
Other Key Products | Linzess | International        
Disaggregation of Revenue        
Net revenues $ 12 $ 11 $ 23 $ 20